Vectus Biosystems Limited

Vectus Biosystems Limitedverified

VBS.AX

Price:

$0.11

Market Cap:

$5.87M

Vectus Biosystems Limited engages in the medical research and development activities in Australia. The company develops treatment for fibrosis and high blood pressure, which include treatments for heart, kidney, liver, and lung diseases. Its lead compound is VB0004, which is aimed at treating the loss of functional tissue to fibrosis, scarring, and high blood pressure. The company also intends to develop candidates for the treatment of fibrotic liver diseases, including non-alcoholic steatohepatitis and pulmonary fibrotic diseases. In addition, it develops AccuCal and RealCount software that enhance speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories. ...[Read more]

Industry

Biotechnology

IPO Date

2016-02-22

Stock Exchange

ASX

Ticker

VBS.AX

The Current Ratio as of December 2025 (TTM) for Vectus Biosystems Limited (VBS.AX) is 0.93

According to Vectus Biosystems Limited’s latest financial reports and current stock price. The company's current Current Ratio is 0.93. This represents a change of -61.06% compared to the average of 2.39 of the last 4 quarters.

Vectus Biosystems Limited (VBS.AX) Historical Current Ratio (quarterly & annually)

How has VBS.AX Current Ratio performed in the past?

The mean historical Current Ratio of Vectus Biosystems Limited over the last ten years is 2.15. The current 0.93 Current Ratio has changed 4.22% with respect to the historical average. Over the past ten years (40 quarters), VBS.AX's Current Ratio was at its highest in in the June 2015 quarter at 24.52. The Current Ratio was at its lowest in in the December 2011 quarter at 0.

Quarterly (TTM)
Annual

Average

2.15

Median

1.56

Minimum

0.06

Maximum

5.09

Vectus Biosystems Limited (VBS.AX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Vectus Biosystems Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 2.39%

Maximum Annual Current Ratio = 5.09

Minimum Annual Increase = -94.43%

Minimum Annual Current Ratio = 0.06

Quarterly (TTM)
Annual
YearCurrent RatioChange
20250.93-72.99%
20243.45-16.76%
20234.14721.79%
20220.50-87.92%
20214.17106.78%
20202.022.39%
20190.0831.70%
20180.06-94.43%
20171.10-78.30%
20165.09-79.25%

Vectus Biosystems Limited (VBS.AX) Average Current Ratio

How has VBS.AX Current Ratio performed in the past?

The current Current Ratio of Vectus Biosystems Limited (VBS.AX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

2.84

5-year avg

2.64

10-year avg

2.15

Vectus Biosystems Limited (VBS.AX) Current Ratio vs. Peers

How is VBS.AX’s Current Ratio compared to its peers?

Vectus Biosystems Limited’s Current Ratio is less than Bio-Gene Technology Limited (3.86), less than Invex Therapeutics Ltd (24.79), greater than Adherium Limited (0.41), less than Biotron Limited (2.23), less than Acrux Limited (1.07), greater than Cann Group Limited (0.12), greater than Invion Limited (0.75), greater than InhaleRx Limited (0.70), greater than HITIQ Limited (0.41), greater than Memphasys Limited (0.25),

Build a custom stock screener for Vectus Biosystems Limited (VBS.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vectus Biosystems Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vectus Biosystems Limited (VBS.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vectus Biosystems Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Vectus Biosystems Limited's Current Ratio?

How is the Current Ratio calculated for Vectus Biosystems Limited (VBS.AX)?

What is the highest Current Ratio for Vectus Biosystems Limited (VBS.AX)?

What is the 3-year average Current Ratio for Vectus Biosystems Limited (VBS.AX)?

What is the 5-year average Current Ratio for Vectus Biosystems Limited (VBS.AX)?

How does the current Current Ratio for Vectus Biosystems Limited (VBS.AX) compare to its historical average?